S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES

por Dickinson, Michael, Hamad, Nada, Bryant, Christian, Kothari, Nishi, Ojeras, Paulius, Vohra, Anmol, Lin, Ming, Tohme, Mira, Trager, James, Shook, David, Kennedy, Glen, Tees, Michael, Hill, Brian T.
Publicado 2023

P628: UPDATED ANALYSIS OF BELLWAVE-001: A PHASE 1/2 OPEN-LABEL DOSE-EXPANSION STUDY OF THE EFFICACY AND SAFETY OF NEMTABRUTINIB FOR THE TREATMENT OF B-CELL MALIGNANCIES

por Woyach, Jennifer, Flinn, Ian W., Awan, Farrukh, Eradat, Herbert, Brander, Danielle M., Tees, Michael, Parikh, Sameer, Phillips, Tycel, Ghori, Razi, Paydar, Ima, Farooqui, Mohammed Z. H., Byrd, John C., Stephens, Deborah
Publicado 2023

Remission of severe myasthenia gravis after autologous stem cell transplantation

por Schlatter, Monica I., Yandamuri, Soumya S., O'Connor, Kevin C., Nowak, Richard J., Pham, Minh C., Obaid, Abeer H., Redman, Callee, Provost, Marie, McSweeney, Peter A., Pearlman, Michael L., Tees, Michael T., Bowen, James D., Nash, Richard A., Georges, George E.
Publicado 2023

PB2346: ZUMA-24: A PHASE 2, OPEN-LABEL, MULTICENTER STUDY OF AXICABTAGENE CILOLEUCEL IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA GIVEN WITH CORTICOSTEROIDS IN THE OU...

por Leslie, Lori, Tees, Michael, Flinn, Ian W., Rodriguez, Tulio, Baird, John H., Deol, Abhinav, Mead, Monica, Bachier, Carlos, Rapoport, Aaron P., Mcclune, Brian, Hoda, Daanish, Perales, Miguel-Angel, Zheng, Yan, Filosto, Simone, Davis1, Madison, Miao, Harry, Kim, Jenny J., Oluwole, Olalekan O.
Publicado 2023

P1107: ZUMA-22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD-OF-CARE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

por Flinn, Ian W., Jacobson, Caron, Nastoupil, Loretta J., Morschhauser, Franck, Davies, Andrew J., Buske, Christian, Corradini, Paolo, Lopez-Guillermo, Armando, Reshef, Ran, Parameswaran, Vinod, Sehgal, Alison, Tees, Michael, Lui, Christine, Xue, Wei, Beygi, Sara, Grechko, Nikolay, Bolsue, Pisita, Giovanetti, Alessandro, To, Christina, Nahas, Myrna
Publicado 2023

PB2319: ZUMA-23: A GLOBAL, PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD OF CARE AS FIRST-LINE THERAPY IN PATIENTS WITH HIGH-RISK LARGE B-CELL LYM...

por Westin, Jason, Jacobson, Caron, Chavez, Julio C, Sureda, Anna, Morschhauser, Franck, Glass, Bertram, Dickinson, Michael, Davies, Andrew J., Flinn, Ian W., Maloney, David, Chamuleau, Martine, Tees, Michael, Xue, Allen, Shahani, Shilpa, Nikolajeva, Olga, Kang, Janet, Kaplan, Aida, Schupp, Marco, Miao, Harry, Rich, Elizabeth Shima
Publicado 2023

P1125: DURABLES RESPONSES ACHIEVED WITH ANTI-CD19 ALLOGENEIC CAR T ALLO-501/501A IN PHASE 1 TRIALS OF AUTOLOGOUS CAR T-NAÏVE PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA...

por Munoz, Javier, Locke, Frederick, Lekakis, Lazaros, Eradat, Herbert, Tees, Michael, de Vos, Sven, Nath, Rajneesh, Stevens, Don, Malik, Shahbaz, Popplewell, Leslie, Hamadani, Mehdi, Oluwole, Olalekan, Perales, Miguel-Angel, Miklos, David, Fisher, Paul, Goyal, Lovely, Navale, Lynn, Kaufman, Gregory, Kai, Kazuharu, Balakumaran, Arun, Neelapu, Sattva
Publicado 2023